Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald
September 20th 6pm EST
Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the Department of Medicine, Epidemiology and Laboratory Medicine & Pathology at the University of Washington and in the Vaccine and Infectious Diseases Division at the Fred Hutchinson Cancer Research Center.
Dr Wald co-directs the University of Washington Virology Research Clinic, a clinic dedicated to the study of epidemiology, natural history and therapeutics for viral infections. Her research has focused on genital herpes infections, including infections in pregnant women and immunocompromised hosts.
Dr. Wald has been an investigator in many clinical trials for novel antiviral agents and prophylactic and therapeutic vaccines for HSV infection, as well as vaccines for HPV, CMV and other viral pathogens. Join us for a talk highlighting promising preclinical research and clinical trials for HSV, the release of Herpes Cure Pipeline 3.0, and hear Dr. Wald’s reflections on where the field has been and where it’s going.
Overview of Prior Efforts
Promising Clinical Research
Highlights from Herpes Cure Pipeline 3.0
The Path to a Cure